您似乎在寻求关于TENM3-ALK融合对神经母细胞瘤的影响，我会试图解释此概念。
Conceptually, a gene fusion happens when two gene segments that typically exist distinctly fuse together to create a chimeric, or hybrid, gene. This new gene could behave in a way that's different from the original separate genes. Such mutations sometimes lead to different diseases, including various forms of cancer.
In this context, TENM3 and ALK are two distinct genes. ALK is an important gene involved in cell growth and division while TENM3 is a member of the teneurin family, which plays a role in nervous system development and function.
TENM3-ALK fusion gene has been identified as a variant of ALK activation in neuroblastoma, which is a type of cancer that most frequently occurs in and around the adrenal glands, which have similar origins to nerve cells and affect small children.
The presence of this novel fusion gene can help physicians identify patients with neuroblastoma and possibly pave the way for targeted therapies. Because it's a fusion gene involving ALK, treatments targeting ALK may be effective. Gene therapy is an up-and-coming field, and it's feasible that such advancements might lead to even better treatments for individuals with conditions like neuroblastoma in the future. |
求助已关闭
30